Alterity Therapeutics (ATHE) Enterprise Value (2009 - 2025)
Alterity Therapeutics (ATHE) posted quarterly Enterprise Value of -$32.3 million for Q4 2025, down 988.88% year-over-year from $3.6 million in Q4 2024, and down 51.93% quarter-over-quarter from -$21.3 million in Q2 2025.
Alterity Therapeutics (ATHE) Enterprise Value (2009 - 2025) Analysis & Trends
Alterity Therapeutics' Enterprise Value history runs 17 years deep, the most recent figure standing at -$32.3 million for Q4 2025.
- In Q4 2025, Enterprise Value fell 988.88% year-over-year to -$32.3 million; the TTM figure through Dec 2025 stood at -$32.3 million (down 988.88% YoY), while the FY2025 annual figure was -$21.3 million, down 154.46% from the prior year.
- Enterprise Value for Q4 2025 stood at -$32.3 million, down from -$21.3 million in the prior quarter.
- The five-year high for Enterprise Value was -$153190.1 in Q2 2024, with the low at -$32.3 million in Q4 2025.
- The 5-year median for Enterprise Value is -$21.5 million (2021), against an average of -$16.4 million.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value surged 99.26% in 2023, then tumbled 13779.93% in 2025.
- Alterity Therapeutics' Enterprise Value stood at -$27.0 million in 2021, then grew by 15.16% to -$22.9 million in 2022, then jumped by 55.1% to -$10.3 million in 2023, then jumped by 71.11% to -$3.0 million in 2024, then tumbled by 988.88% to -$32.3 million in 2025.
- Business Quant data shows ATHE's Enterprise Value at -$32.3 million in Q4 2025, -$21.3 million in Q2 2025, and -$3.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.47 Bn | 131.61 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.36 Bn | 78.37 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 58.99 Bn | 53.85 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.74 Bn | 28.43 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.01 Bn | 9.61 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | 2.12 Bn |
| 10 | Alterity Therapeutics | 49.04 Mn | 16.74 Mn | - | -32.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -32.30 Mn |
| Jun 30, 2025 | -21.26 Mn |
| Dec 31, 2024 | -2.97 Mn |
| Jun 30, 2024 | -153,190.06 |
| Dec 31, 2023 | -10.27 Mn |
| Jun 30, 2023 | -184,314.51 |
| Dec 31, 2022 | -22.87 Mn |
| Jun 30, 2022 | -24.94 Mn |
| Dec 31, 2021 | -26.96 Mn |
| Jun 30, 2021 | -21.65 Mn |
| Dec 31, 2020 | -25.61 Mn |
| Jun 30, 2020 | -6.03 Mn |
| Dec 31, 2019 | -8.32 Mn |
| Jun 30, 2019 | -10.09 Mn |
| Dec 31, 2018 | -10.93 Mn |
| Jun 30, 2018 | -11.53 Mn |
| Dec 31, 2017 | -16.84 Mn |
| Jun 30, 2017 | -16.55 Mn |
| Dec 31, 2016 | -21.45 Mn |
| Jun 30, 2016 | -21.35 Mn |